EP1545210A1 - Stable, low free formaldehyde, synergistic antimicrobial compositions of aldehyde donors and dehydroacetic acid - Google Patents

Stable, low free formaldehyde, synergistic antimicrobial compositions of aldehyde donors and dehydroacetic acid

Info

Publication number
EP1545210A1
EP1545210A1 EP03793156A EP03793156A EP1545210A1 EP 1545210 A1 EP1545210 A1 EP 1545210A1 EP 03793156 A EP03793156 A EP 03793156A EP 03793156 A EP03793156 A EP 03793156A EP 1545210 A1 EP1545210 A1 EP 1545210A1
Authority
EP
European Patent Office
Prior art keywords
composition
mixture
product
products
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP03793156A
Other languages
German (de)
French (fr)
Other versions
EP1545210B1 (en
Inventor
Patrick Jay Lutz
Ahmed M. Tafesh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lonza LLC
Original Assignee
Lonza AG
Lonza LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza AG, Lonza LLC filed Critical Lonza AG
Publication of EP1545210A1 publication Critical patent/EP1545210A1/en
Application granted granted Critical
Publication of EP1545210B1 publication Critical patent/EP1545210B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/501,3-Diazoles; Hydrogenated 1,3-diazoles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N35/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
    • A01N35/02Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing aliphatically bound aldehyde or keto groups, or thio analogues thereof; Derivatives thereof, e.g. acetals

Definitions

  • the present invention relates to stable, low free formaldehyde
  • synergistic antimicrobial mixtures of a first component including one or more
  • aldehyde donor a second component including a stabilizer
  • a third component a stabilizer
  • Such products include personal care products such as shampoos, creams, lotions, cosmetics, and soaps; household
  • personal care product compositions provide a nutrient- rich media which benefit from the incorporation of preservatives to control the
  • Formaldehyde derivatives are known preservatives. For example,
  • Patent No. 5,405,862 teaches a formaldehyde donor composition containing
  • dimethylhydantoin having less than 0.1 % by weight of free formaldehyde based
  • U.S. Patent No. 6,143,204 discloses a broad spectrum
  • preservative composition having a dialkanol-substituted dimethyl hydantoin, an
  • Patent No. 6,121,302 teaches a broad spectrum preservative having a dialkanol-
  • Dehydroacetic acid or its salts thereof is also a known preservative, exhibiting both fungicidal and bactericidal activity.
  • product such as instability, odor, and breakdown of product is greater.
  • the antimicrobial composition should contain
  • the antimicrobial composition suitable for use in personal care and household products.
  • the antimicrobial composition is suitable for use in personal care and household products.
  • the first component includes one or more alkanol-substituted
  • the second component includes a stabilizer of dimethyl
  • synergistic antimicrobial composition is that it is able to fully control a broader
  • this antimicrobial composition is
  • a particularly advantageous aspect of the invention is that a small amount of dehydroxyacetic acid (DHA) in combination with one or more aldehyde
  • hydantoin serves to minimize the amount of free formaldehyde, thus eliminating the
  • the antimicrobial composition containing more solids than a typical hydantoin or typical hydantoin in combination with DHA,
  • the antimicrobial composition does not freeze or
  • the antimicrobial composition may be used in personal care products such as shampoos, conditioners, rinses, creams, lotions, dental care products such as shampoos, conditioners, rinses, creams, lotions, dental care products such as shampoos, conditioners, rinses, creams, lotions, dental care products such as shampoos, conditioners, rinses, creams, lotions, dental care products such as shampoos, conditioners, rinses, creams, lotions, dental care products such as shampoos, conditioners, rinses, creams, lotions, dental care products such as
  • the antimicrobial composition can be added to the aforementioned products or
  • the components of the synergistic antimicrobial composition are easy
  • the components are physically and chemically compatible and may be combined with carriers and excipients.
  • Personal care products, household products, and industrial products comprising the antimicrobial composition are further provided by this invention.
  • inhibiting microbial growth describe the killing of, as well as the inhibition of, or
  • an “antimicrobial effective amount” is an amount effective to inhibit the growth of and/or kill microorganisms.
  • the first component of the antimicrobial composition includes one or more aldehyde
  • aldehyde refers to any compound that has an aldehyde
  • aldehydes that exhibit antimicrobial activity such as formaldehyde, orthophthalaldehyde, cinnamaldehyde, and mixtures thereof.
  • aldehyde donor as used herein is defined as any material
  • aldehyde or a compound which gives positive reactions with aldehyde identifying
  • aldehyde identifying reagents examples include, but are not limited to,
  • Suitable aldehyde donors include, but are not limited to,
  • methenamine 5-bromo-5-nitro-l,3-dioxane, sodium hydroxymethylglycinate
  • aldehyde donors include, but are not limited to alkanol- substituted dimethyl hydantoins having the formula:
  • Ri and R2 are each independently hydrogen or (CH 2 )OH, with the proviso
  • Ri and R- cannot both be hydrogen
  • R- ⁇ and R are each independently hydrogen, a methyl group, and ethyl group, a propyl group, or an aryl group.
  • Alkanol-substituted dimethylhydantoin compounds include those
  • MDMH dimethylhydantoin
  • 3-methylol-5,5-dimethylhydantoin 1-
  • mixtures include, but are not limited to, Glydant 2000 ® , a 70% solution of hydantoin species including about 36% dimethylol dimethyl hydantoin (DMDMH),
  • MMDMH monomethylol dimethylhydantoin
  • DMH dimethyl hydantoin
  • Glydant 2000 ® has a total formaldehyde content of 17% .
  • MDMH monomethylol dimethylhydantoin
  • DMH dimethyl hydantoin
  • the second component includes stabilizers including hydantoins and
  • hydantoins are represented by formula:
  • Ri to R 4 are independently selected from H, and a G to C ⁇ alkyl group.
  • the stabilizer is 5, 5-dimethy -hydantoin.
  • the stabilizers used in the invention may also include urea and its
  • the third component includes dehydroacetic acid or its salts thereof;
  • Water is the preferred solvent for use in the present invention.
  • a hydroxyl solvent can be used which includes mono-, di-, and
  • polyhydroxyl alcohols For example, monohydroxyl alcohols having from about 1
  • alcohols e.g. , glycols
  • C2 to Cs diols e.g. , propylene glycol and butylene
  • glycol are advantageous.
  • Other compounds which can be used include dipropylene
  • glycol glycerin, diglycerin, PPG-9, PPG02-buteth-2, butoxypropanol, butoxydiglycol, PPG-2 butyl ether, glycereth-7, sorbitol, isopentyldiol, myristyl
  • This formulation has a free formaldehyde concentration of less than
  • formaldehyde concentration is from 5% to 25% by weight and preferably from 12%
  • the blend contains little or no free formaldehyde.
  • Table 1 provides ranges for the broad spectrum synergistic
  • antimicrobial composition concentrates of the invention.
  • spectrum concentrate may broadly be from about 1: 100 to 100: 1, preferably from
  • the final product to be preserved For example, the optimum amount of
  • antimicrobial composition to use for preserving an aqueous composition can be
  • the use level is generally 0.00005% (0.5 ppm) to 5% (50,000 ppm) by weight
  • Preservative formulations of the invention can also be used directly as they are manufactured without dilution, or in any other manner traditionally used in
  • Antimicrobial compositions of this invention may be used directly as
  • the antimicrobial compositions may be pumped into medium sized batches (from
  • the antimicrobial composition of the invention may also be metered
  • the stabilizer may be any organic compound.
  • the stabilizer may be any organic compound.
  • the resulting composition can be used in making the antimicrobial composition of the
  • aldehyde donor such as alkanol-substituted
  • the stabilizer DMH also serves to minimize the amount of free formaldehyde in the
  • the amount of DMH typically present in alkanol- substituted dimethyl hydantoin compositions is not sufficient to stabilize DHA
  • the total alkyl hydantoin concentration is equal to free alkyl hydantoin plus reacted alkyl hydantoin (e.g., the DMH in the condensation products MMDMH and DMDMH).
  • the “total" aklyl hydantoin concentration is different from the “added” alkyl hydantoin concentration. Since alkyl hydantoin (free and reacted)
  • alkyl hydantoin may be added to achieve a stabilizing amount for DHA.
  • alkyl hydantoin is added to a prepared alkanol-substituted
  • dimethyl hydantoin composition e.g. , Glydant 2000 ®
  • Glydant 2000 ® dimethyl hydantoin composition
  • alkyl hydantoin such that the added alkyl hydantoin in combination with the
  • alkylhydantoin in the alkanol-substituted dimethyl hydantoin composition provide a
  • Glydant ® is a 55% solution of l,3-dimethylol-5,5-dimethyl hydantoin
  • QA is the quantity of Compound A in mixture, producing an endpoint
  • the synergistic antimicrobial composition of the present invention is
  • Table 3 illustrates the levels at which the individual components Glydant ® 2000 and
  • DHA are effective and ineffective against bacteria.
  • the antimicrobial composition described herein provides a
  • compositions i.e., personal care products, household
  • the antimicrobial composition eliminates the need for iodine, while at the same time utilizing ultra-low free formaldehyde compositions in combination with DHA or DHA.Na which is fungicidal and bactericidal.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)

Abstract

The present invention provides a stable, low free formaldehyde, synergistic antimicrobial composition, and a method of inhibiting the growth of or reducing microorganisms by applying the composition. Preferably, the constituents are dimethylol dimethylhydantoin, monomethylol dimethylhydantoin, dimethyl hydantoin, and dehydroacetic acid or its salts thereof. The composition has a free formaldehyde content of less than 0.2% and is beneficial for controlling microbiological and fungal contamination in personal care products, household products and industrial products and systems.

Description

STABLE, LOW FREE FORMALDEHYDE, SYNERGISTIC ANTIMICROBIAL COMPOSITIONS OF ALDEHYDE DONORS AND
DEHYDROACETIC ACID
Field of the Invention The present invention relates to stable, low free formaldehyde,
synergistic antimicrobial mixtures of a first component including one or more
aldehyde donor, a second component including a stabilizer; and a third component
including dehydroacetic acid or salt thereof.
Background of the Invention
The need for effective and economical preservative compositions is
well known. Many products require the addition of a preservative to protect against
contamination and growth of microbes. Examples of such products include personal care products such as shampoos, creams, lotions, cosmetics, and soaps; household
products such as laundry detergents, hard surface cleaners, fabric softeners, and
various industrial products; such as paint, wood, textiles, adhesives, sealants,
leather, rope, paper pulp, plastics, fuel, oil, and rubber and metal working fluids. The control of slime-producing bacterial and fungi in pulp and paper mills and in
cooling towers is also a matter of substantial commercial importance.
In particular, personal care product compositions provide a nutrient- rich media which benefit from the incorporation of preservatives to control the
growth of microorganisms and to prevent spoilage. Generally, the shelf life of these
products depends on the resistance to microbial spoilage of components contained
therein. It is therefore desirable to formulate a preservative which controls microbial contamination in personal care products, household products, and
industrial products.
Formaldehyde derivatives are known preservatives. For example,
U.S. Patent No. 3,987,184 discloses l,3-dimethylol-5,5-dimethylhydantoin
(DMDMH) useful as a formaldehyde donor compound for the preservation of
personal care products, cosmetics, and household and industrial products. U.S.
Patent No. 5,405,862 teaches a formaldehyde donor composition containing
dimethyloldimethylhydantoin, monomethyloldimethylhydantoin, and
dimethylhydantoin having less than 0.1 % by weight of free formaldehyde based
upon 100% of total composition, useful in biocidal effective amounts in industrial or
personal care products. U.S. Patent No. 6,143,204 discloses a broad spectrum
preservative composition having a dialkanol-substituted dimethyl hydantoin, an
iodopropynyl compound, a stabilizer of hydantoin, and a hydroxyl solvent. U.S.
Patent No. 6,121,302 teaches a broad spectrum preservative having a dialkanol-
substituted dimethyl hydantoin, one or more isothazolones, a hydantoin stabilizer and a hydroxyl solvent. Dehydroacetic acid or its salts thereof is also a known preservative, exhibiting both fungicidal and bactericidal activity.
While useful for controlling bacteria, fungi and other contamination
in personal care and household products, these substances present a variety of limitations for such use including being unduly expensive; exhibiting limited antimicrobial or antifungal activity, or limited solubility in water; exhibiting undue pH
dependence; adverse toxicological properties and skin sensitization or possible
carcinogenicity; or they may be inactivated by commonly used materials.
Furthermore, to obtain full microbiological control, a great amount of preservative must be added to the product, making it more difficult to formulate. Also, when
large amounts of additive are used, the likelihood of a negative impact on that
product, such as instability, odor, and breakdown of product is greater.
In light of the foregoing, it would be advantageous to formulate a
broad spectrum antimicrobial composition which completely controls
microbiological and fungal contamination in personal care products, household
products, and industrial products. The antimicrobial composition should contain
low free formaldehyde and iodine levels; and should be cost effective, stable, and
suitable for use in personal care and household products. The antimicrobial
composition should also be easy to formulate and effective at concentrations low
enough so as not to adversely impact the product to which it is added.
Summary of the Invention In accordance with the invention, it has now been discovered that a
stable, low free formaldehyde, synergistic antimicrobial combination of a first
component including one or more aldehyde donor, a second component including a stabilizer; and a third component including dehydroacetic acid or salt thereof, gives
both broad spectrum bactericidal and fungicidal activity suitable for use in personal
care products, household products, and various industrial products and systems. Preferably, the first component includes one or more alkanol-substituted
dimethylhydantoin, and the second component includes a stabilizer of dimethyl
hydantoin. Particular advantages of the antimicrobial composition of the invention
are the low amounts of free formaldehyde, i.e., less than 0.2% .
By combining these components in products which require protection
against microbial attack, an antimicrobial composition which completely controls microbiological contamination is obtained. Furthermore, due to the synergistic
effect of the components, much less active material of each component is required
as opposed to when each component is used alone. Another advantage of the
synergistic antimicrobial composition is that it is able to fully control a broader
spectrum of bacteria and fungi than any of the individual components. A further
advantage is that the antimicrobial composition requires no iodine which at high
levels is considered toxic. Accordingly, this antimicrobial composition is
economical, requiring lesser amounts of expensive components, easy to use, and
less likely to have toxic or skin sensitizing effects on individuals exposed to the product. A particularly advantageous aspect of the invention is that a small amount of dehydroxyacetic acid (DHA) in combination with one or more aldehyde
donor, and a stabilizer such as dimethyl hydantoin forms a stable composition. This
activity could in no way be predicted based on the known reaction of dehydroacetic
acid sodium salt with formaldehyde released from aldehyde donors in aqueous solution. The interaction and declining levels of dehydroacetic acid sodium salt was
shown by NMR analysis in literature in the Journal of Society of Cosmetic
Chemists, entitled "Dehydroacetic acid sodium salt stability in cosmetic preservative
mixtures, " by C.A. Bennassi, et al., Vol. 10, pp. 29-37 (1988). This reaction
forms an unstable composition, decreasing levels of DHA, thereby eliminating the
fungicidal and bactericidal effect of DHA. Inclusion of a stabilizer such as dimethyl
hydantoin serves to minimize the amount of free formaldehyde, thus eliminating the
reaction of free formaldehyde with DHA.
Another advantage is that the antimicrobial composition of the
invention remains stable and does not freeze at temperatures as low as -15° C. The
more solids there are in a mixture, the more likely that the freezing point of the
mixture will be increased. A typical hydantoin, and a typical hydantoin in
combination with a dehydroxyacetic acid or salt thereof, freezes at -15° C.
Therefore, it would be likely that the antimicrobial composition, containing more solids than a typical hydantoin or typical hydantoin in combination with DHA,
would freeze at -15° C. However, the antimicrobial composition does not freeze or
form crystals at -15° C; thus, this activity could in no way be predicted as a typical hydantoin, and a typical hydantoin in combination with a dehydroacetic acid or salt
thereof forms crystals at -15° C.
The antimicrobial composition may be used in personal care products such as shampoos, conditioners, rinses, creams, lotions, dental care products such
as mouthwash, toothpaste, spray, and denture cleaners or soaks, baby wipes and other woven and non- woven wipes; household products such as detergents, hard
surface cleaners, fabric softeners, and the like; and industrial products such as paint,
wood, wood treatment, paper board, sheet rock, paper pulp, ceiling tiles, textiles, adhesives, sealants, leather, rope, plastics, petroleum, fuel, oil, and rubber and
metal working fluids; or industrial systems such as pulp and papermaking
processing, water treatment systems, cooling water, swimming pools and spas,
decorative fountains, membranes, brewery pastures, toilet and urinal applications,
food and beverage sanitation, sporicidal formulations, sterilization of clinical
products and surgical instruments, and preservation including clay slurry and starch.
The antimicrobial composition can be added to the aforementioned products or
systems already formulated or the three components can be added to the products or
systems separately.
The components of the synergistic antimicrobial composition are easy
to formulate and may be added to an article or system to be treated as separate
entities, or as a combination. The components are physically and chemically compatible and may be combined with carriers and excipients. Methods for inhibiting the growth of or reducing microorganisms in
personal care, household, or industrial products or systems are also provided by this invention.
Personal care products, household products, and industrial products comprising the antimicrobial composition are further provided by this invention.
Detailed Description of the Invention
As used herein, the phrases "antimicrobial," "biocidal," and
"inhibiting microbial growth" describe the killing of, as well as the inhibition of, or
control of, the growth of bacteria, yeasts, fungi, and algae.
As used herein, the phrase "microbiological contamination" describes
contamination against microbes including bacteria, yeasts, fungi, and algae.
An "antimicrobial effective amount" is an amount effective to inhibit the growth of and/or kill microorganisms.
The first component of the antimicrobial composition includes one or more aldehyde
donor.
Aldehyde and Aldehyde Donor
The term "aldehyde" refers to any compound that has an aldehyde
group, especially those aldehydes that exhibit antimicrobial activity, such as formaldehyde, orthophthalaldehyde, cinnamaldehyde, and mixtures thereof.
The term "aldehyde donor" as used herein is defined as any material
which is not an aldehyde but upon aqueous dilution liberates a compound which gives positive reactions with aldehyde identifying reagents, i.e. , a compound which
can identify aldehyde groups. Generally the liberated compound has the formula:
O OH
R- -H or R H
OH
where R is any functional group. In other words, the term "aldehyde donor"
includes any compound which is not an aldehyde but when hydrolyzed forms an
aldehyde or a compound which gives positive reactions with aldehyde identifying
reagents. Examples of aldehyde identifying reagents include, but are not limited to,
Benedicts solution, Tollens reagent, and acetyl acetone.
Suitable aldehyde donors include, but are not limited to,
imidazolidinyl urea, Quaternium-15, diazolindinyl urea, bromonitropropane diol,
methenamine, 5-bromo-5-nitro-l,3-dioxane, sodium hydroxymethylglycinate,
formalin, glutar aldehyde, polymethoxy bicyclic oxazolidine, 3,5-dimethyl-l,3,5,2H- tetrahydrothiadiazine-2-thione , hexahydro- 1 , 3 , 5-tris(2-hydroxyethyl)triazine ,
hexahydo-l,3,5-triethyl-s-triazine, methylolhydantoins, tetrakis (hydroxymethyl)
phosphonium sulfate, and any combination of any of the foregoing.
Preferred aldehyde donors include, but are not limited to alkanol- substituted dimethyl hydantoins having the formula:
wherein Ri and R2 are each independently hydrogen or (CH2)OH, with the proviso
that both Ri and R- cannot both be hydrogen, and R-ι and R are each independently hydrogen, a methyl group, and ethyl group, a propyl group, or an aryl group.
Alkanol-substituted dimethylhydantoin compounds include those
described in U.S. Patent Nos. 3,987, 184 and 4, 172,140. These are condensation
products of 5,5-dimethylhydantoin (DMH) with one or more moles of formaldehyde
(e.g. l,3-dimethylol-5,5-dimethylhydantoin (DMDMH), l-methylol-5,5-
dimethylhydantoin (MMDMH), or 3-methylol-5,5-dimethylhydantoin and 1-
methylol-3-methyloloxymethylene-5,5-dimethylhydantoin, and mixtures thereof).
Mixtures of alkanol-substituted DMH compounds can also be used. Preferred
mixtures include, but are not limited to, Glydant 2000®, a 70% solution of hydantoin species including about 36% dimethylol dimethyl hydantoin (DMDMH),
about 29% monomethylol dimethylhydantoin (MMDMH), and about 5% dimethyl hydantoin (DMH); and 30% water, available from Lonza Inc. of Fair Lawn, New
Jersey. Glydant 2000® has a total formaldehyde content of 17% . Dantogard®2000
is a 70% solution of equilibrated dimethylol dimethyl hydantoin (DMDMH),
monomethylol dimethylhydantoin (MMDMH), and dimethyl hydantoin (DMH), (17% total formaldehyde content), available from Lonza Inc. of Fair Lawn, New
Jersey.
The second component includes stabilizers including hydantoins and
their derivatives. The hydantoins are represented by formula:
where Ri to R4 are independently selected from H, and a G to Cδ alkyl group.
Preferably the stabilizer is 5, 5-dimethy -hydantoin.
The stabilizers used in the invention may also include urea and its
derivatives.
The third component includes dehydroacetic acid or its salts thereof;
for example, dehydroacetic acid sodium salt.
Water is the preferred solvent for use in the present invention.
Optionally, a hydroxyl solvent can be used which includes mono-, di-, and
polyhydroxyl alcohols. For example, monohydroxyl alcohols having from about 1
to 5 carbon atoms, most preferably ethanol and propanol, may be used. Dihydroxyl
alcohols (e.g. , glycols) such as C2 to Cs diols (e.g. , propylene glycol and butylene
glycol) are advantageous. Other compounds which can be used include dipropylene
glycol, glycerin, diglycerin, PPG-9, PPG02-buteth-2, butoxypropanol, butoxydiglycol, PPG-2 butyl ether, glycereth-7, sorbitol, isopentyldiol, myristyl
myristate, and phenoxy ethanol.
This formulation has a free formaldehyde concentration of less than
1 % by weight, preferably less than 0.5, 0.2, or 0.1 % by weight. Total
formaldehyde concentration is from 5% to 25% by weight and preferably from 12%
to 18% by weight. Preferably, the blend contains little or no free formaldehyde.
Low free formaldehyde compositions reduce workplace exposure risk to
formaldehyde resulting in greater safety and reduced regulatory issues.
Table 1 provides ranges for the broad spectrum synergistic
antimicrobial composition concentrates of the invention.
The ratio of the aldehyde donor to DHA or salt thereof for the broad
spectrum concentrate may broadly be from about 1: 100 to 100: 1, preferably from
about 1:60 to 60: 1, and more preferably from 0.05:30 to 30:0.05 and the ratio of
stabilizer, such as dimethyl hydantoin, to aldehyde donor sufficient to minimize the
amount of free formaldehyde, thus reducing or preventing the reaction of free
formaldehyde with DHA. The preservative concentrates of the invention can be readily
prepared in accordance with procedures well known to those skilled in the art,
simply by mixing the components set forth in Table 1 , supra, and adjusting the pH using any organic or mineral acid (e.g., hydrochloric acid and acetic acid) suitable
for the user's purpose. The manner in which the components are mixed can be
modified to suit the needs of the formulator, as discussed below, without departing from the spirit of the invention.
The concentration of the active compounds in the use dilution
depends on the nature of the microorganisms to be combated and the composition of
the final product to be preserved. For example, the optimum amount of
antimicrobial composition to use for preserving an aqueous composition can be
determined by means of screening tests known in the art, and in accordance with the formulation ranges provided in Table 1. When preserving an aqueous composition,
the use level is generally 0.00005% (0.5 ppm) to 5% (50,000 ppm) by weight,
preferably from about 0.01 % (100 ppm) to 1 % (10,000 ppm) of the final
composition. Preservative formulations of the invention can also be used directly as they are manufactured without dilution, or in any other manner traditionally used in
manufacturing, such as by metering.
Antimicrobial compositions of this invention may be used directly as
they are manufactured, without dilution. They may be poured into small batches
(from one to thousands of pounds) of product at any point in its manufacture. Also,
the antimicrobial compositions may be pumped into medium sized batches (from
thousands to tens of thousands of pounds). The antimicrobial composition of the invention may also be metered
continuously from a storage tank into large sized production runs (from tens of
thousands to millions of pounds) in systems custom-designed to continuously mix all the components of the finished product at approximately the same rate that it is filled into its final package. The blending elements of continuous mixers are mostly
shaped in the form of spirals or screws, effecting on rotation both a mixing and a
transport of the product composition.
Because start-up is very labor-intensive, to insure all the metering
equipment is properly calibrated, these systems are generally used only for very high volume, long and continuous production runs.
In another embodiment of the invention, the stabilizer may be
combined with the DHA. A hydroxyl solvent may be added if desired. The resulting composition can be used in making the antimicrobial composition of the
invention by mixing it with one or more aldehyde donor, such as alkanol-substituted
dimethyl hydantoin.
In the antimicrobial composition containing both active ingredients,
the stabilizer DMH also serves to minimize the amount of free formaldehyde in the
composition. In some instances, the amount of DMH typically present in alkanol- substituted dimethyl hydantoin compositions is not sufficient to stabilize DHA where
two active ingredients are used. Therefore, when formulating a stabilized
antimicrobial composition of the invention, the total alkyl hydantoin concentration
must be considered in determining how much alkyl hydantoin should be added to
stabilize the DHA. The total alkyl hydantoin concentration is equal to free alkyl hydantoin plus reacted alkyl hydantoin (e.g., the DMH in the condensation products MMDMH and DMDMH).
The "total" aklyl hydantoin concentration is different from the "added" alkyl hydantoin concentration. Since alkyl hydantoin (free and reacted)
may be present in certain alkanol-substituted dimethyl hydantoin compositions, an
amount of alkyl hydantoin may be added to achieve a stabilizing amount for DHA. Thus in one embodiment alkyl hydantoin is added to a prepared alkanol-substituted
dimethyl hydantoin composition (e.g. , Glydant 2000®) that contains free and reacted
alkyl hydantoin, such that the added alkyl hydantoin in combination with the
alkylhydantoin in the alkanol-substituted dimethyl hydantoin composition provide a
total alkyl hydantoin concentration that stabilizes DHA.
Glydant® is a 55% solution of l,3-dimethylol-5,5-dimethyl hydantoin
(DMDMH) available from Lonza, Inc. of Fair Lawn, New Jersey.
A synergistic effect is a response to a combination of two or more
components that produce an effect greater than the sum of their individual effects.
One method for determining whether a composition exhibits a synergistic effect is
the method described in C.E. Kull et al. , "Mixtures of Quaternary Ammonium
Compounds and Long-chain Fatty Acids as Antifungal Agents", Applied
Microbiology, 9:538-541 (1961). The synergism value is determined by the
formula:
where QA is the quantity of Compound A in mixture, producing an endpoint; Qa is
the quantity of Compound a acting alone, producing an endpoint; QB is the concentration of Compound B in the mixture, producing an endpoint. Qb is the
concentration of Compound b acting alone, producing an endpoint.
When the value of (QA/Q3 + Q-./Q-) is less than one, the mixture is
synergistic. Values for (QA/Q3 + Q-?/Qb) of 1 and greater than 1 , represent an
additive effect and an antagonistic effect, respectively. According to this method of
measuring synergism, the quantity of each component in the various mixtures is
compared with the quantity of pure component that is required to reach the same
endpoint or to produce the same microbiological effect as the mixture.
The synergistic antimicrobial composition of the present invention is
useful as an antimicrobial agent in personal care products, dental products,
household products, and industrial products and systems.
The following examples are illustrative of the antimicrobial
composition, however, it is understood that the invention is not limited to the
specific details set forth in the examples.
Table 2
Freezer Stability of NaDHA.H2O in Glydant 2000® and Glydant®
Preservative Challenge Test Results against Mixed Bacteria in Anionic Protein Shampoo
Mixed bacteria challenge tests were performed by adding
approximately 1-5 X 106 organisms per gram of formulation, the organisms
comprising an equally divided mixture of Staphylococcus aureus (ATCC No. 6538), Pseudomonas aeruginosa (ATCC No. 9027), and Escherichia coli (ATCC No.
8739) incubated at ~ 36°C on nutrient agar slants 24 hours prior to testing. The test
samples were incubated at ~ 23°C (room temperature) for the number of days
indicated, after which an aliquot of the sample was taken and diluted stepwise to a
106 fold reduction in concentration. The diluted samples were plated out on tryptic
soy agar and incubated for 48 hours at ~ 36°C. After incubation, readings of the
total number of colony forming units per gram (cfu/g) were made on the samples.
Table 3 illustrates the levels at which the individual components Glydant®2000 and
DHA are effective and ineffective against bacteria.
Table 3
Preservative Challenge Test Results against Mixed Bacteria1 in Anionic Protein
Shampoo
1 An equal mixture of Staphylococcus aureus (ATCC No. 6538), Pseudomonas aeruginosa (ATCC No. 9027), and Escherichia coli (ATCC No. 8739). cfg/g = Colony forming units in 1 gram.
Table 4
Synergy at Day 14
Thus, the antimicrobial composition described herein provides a
method for inhibiting the growth of or reducing microorganisms such as bacteria
and fungi in a wide variety of compositions, i.e., personal care products, household
products, and industrial products and systems. The antimicrobial composition eliminates the need for iodine, while at the same time utilizing ultra-low free formaldehyde compositions in combination with DHA or DHA.Na which is fungicidal and bactericidal.
All patents, applications, articles, publications, and test methods
mentioned above are hereby incorporated by reference.
Many variations of the present invention will suggest themselves to
those skilled in the art in light of the above detailed description. Such obvious
variations are within the full intended scope of the appended claims.

Claims

WE CLAIM: 1. An antimicrobial composition comprising a synergistic antimicrobial
effective amount of a mixture of:
(a) a first component including one or more aldehyde donor; (b) a second component including a stabilizer; and
(c) a third component including a dehydroacetic acid or salt thereof.
2. The composition of claim 1 wherein the dehydroacetic acid salt is
dehydroacetic acid sodium salt.
3. The composition of claim 1 wherein the aldehyde donor is an alkanol-
substituted dimethyl hydantoin selected from the group consisting of 1 ,3-dimethylol-
5,5-dimethylhydantoin, l-methylol-5,5-dimethylhydantoin, 3-methylol-5,5- dimethylhydantoin, l-methylol-3-methyloloxymethylene-5 ,5-dimethylhydantoin,
l,3-dimethyloloxymethylene-5,5-dimethylhydantoin, or mixtures thereof.
4. The composition of claim 3, wherein the alkanol-substituted dimethyl
hydantoin is a mixture of dimethyloldimethylhydantoin and
monomethyloldimethylhydantoin.
5. The composition of claim 1, wherein the aldehyde donor is selected
from the group consisting of imidazolidinyl urea, Quaternium-15, diazolindinyl urea, bromonitropropane diol, methenamine, 5-bromo-5-nitro-l,3-dioxane, sodium
hydroxymethylglycinate, formalin, glutaraldehyde, polymethoxy bicyclic
oxazolidine, 3,5-dimethyl-l,3,5,2H-tetrahydrothiadiazine-2-thione, hexahydro-
l,3,5-tris(2-hydroxyethyl)triazine, hexahydo-l,3,5-triethyl-s-triazine, methylolhydantoins, tetrakis (hydroxymethyl) phosphonium sulfate, or mixtures
thereof.
6. The composition of claim 1 wherein the stabilizer is dimethyl
hydantoin or derivative thereof.
7. The composition of claim 1, wherein the mixture is substantially free
of iodine.
8. The composition of claim 1, wherein the mixture has a free
formaldehyde concentration of less than 0.2% by weight, based on 100% weight of
the mixture.
9. The composition of claim 1 wherein the first component is present in
the mixture in an amount of between about 20% to about 95% by weight, based on
100% by weight of the mixture.
10. The composition of claim 1 wherein the second component is present
in the mixture an amount of between about 0% to about 30% by weight, based on
100% weight of the mixture.
11. The composition of claim 1 wherein the third component is present in
the mixture in an amount of between about 0.5% to about 40% by weight, based on
100% weight of the mixture.
12. A method of preparing a synergistic antimicrobial composition which
comprises blending 20 to 95 parts of an aldehyde donor and 5 to 20 parts of a stabilizer or derivative thereof to form a homogeneous mixture, mixing a solvent
and 1 to 40 parts of DHA or salt thereof with the foregoing mixture to obtain a homogeneous solution containing a total formaldehyde content of at least 2% and less than 0.2% free formaldehyde.
13. A method of inhibiting the growth of or reducing microorganisms
comprising applying a synergistically antimicrobial effective amount of the composition of claim 1.
14. A method of inhibiting the growth of or reducing microorganisms in
personal care products such as shampoos, conditioners, rinses, creams, lotions,
cosmetics, soaps, dental products such as mouthwash, toothpaste, spray, denture
cleaners and denture soaks, baby wipes and other woven and non- woven wipes;
household products such as laundry detergents, hard surface cleaners, fabric softeners; and industrial products such as paint, wood, wood treatment, paper
board, sheet rock, paper pulp, ceiling tiles, textiles, adhesives, sealants, leather,
rope, plastics, petroleum, fuel, oil, and rubber and metal working fluids; comprising
applying an effective amount of the composition of claim 1 to the personal care
product, household product, or industrial product.
15. A method of inhibiting the growth of or reducing microorganisms in
industrial systems such as pulp and papermaking processing; water treatment
systems; cooling water; swimming pools and spas; decorative fountains;
membranes; brewery pastures; toilet and urinal applications; food and beverage sanitation; sporicidal formulations; sterilization of clinical products and surgical instruments, and preservation, including clay slurry and starch, comprising applying an effective amount of the composition of claim 1 to the industrial system.
16. A personal care, household, or industrial product comprising the
composition of claim 1.
17. A personal care, household, or industrial product which comprises an
effective amount of a mixture of a first component including one or more aldehyde donor, and a second component including dimethyl hydantoin, and a third
component including dehydroacetic acid.
18. The product of claim 17 wherein the product is a household or industrial product selected from the group consisting of fabric softeners, laundry
detergents, hard surface cleaners, paint, wood, wood treatment, paper board, sheet
rock, paper pulp, ceiling tiles, textiles, adhesives, sealants, leather, rope, plastics,
petroleum, fuel, oil, and rubber and metal working fluids.
19. The product of claim 17 wherein the product is a personal care
product selected from the group consisting of shampoos, conditioners, rinses,
creams, lotions, cosmetics, soaps, mouthwash, toothpaste, spray, denture cleaners
and denture soaks, baby wipes and other woven and non-woven wipes.
EP03793156A 2002-08-20 2003-08-20 Stable, low free formaldehyde, synergistic antimicrobial compositions of aldehyde donors and dehydroacetic acid Expired - Lifetime EP1545210B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40503602P 2002-08-20 2002-08-20
US405036P 2002-08-20
PCT/US2003/026034 WO2004017736A1 (en) 2002-08-20 2003-08-20 Stable, low free formaldehyde, synergistic antimicrobial compositions of aldehyde donors and dehydroacetic acid

Publications (2)

Publication Number Publication Date
EP1545210A1 true EP1545210A1 (en) 2005-06-29
EP1545210B1 EP1545210B1 (en) 2007-01-24

Family

ID=31946803

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03793156A Expired - Lifetime EP1545210B1 (en) 2002-08-20 2003-08-20 Stable, low free formaldehyde, synergistic antimicrobial compositions of aldehyde donors and dehydroacetic acid

Country Status (17)

Country Link
US (1) US20040102501A1 (en)
EP (1) EP1545210B1 (en)
JP (1) JP2005536552A (en)
KR (1) KR20050058426A (en)
CN (1) CN100456932C (en)
AT (1) ATE352204T1 (en)
AU (1) AU2003259934B2 (en)
BR (1) BR0313610A (en)
CA (1) CA2495893A1 (en)
CR (1) CR7730A (en)
DE (1) DE60311486T2 (en)
EC (1) ECSP055667A (en)
ES (1) ES2279217T3 (en)
MX (1) MXPA05001977A (en)
NZ (1) NZ538638A (en)
WO (1) WO2004017736A1 (en)
ZA (1) ZA200501309B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10244442A1 (en) * 2002-09-24 2004-04-01 Schülke & Mayr GmbH Low-emission formaldehyde depot preparations and their use
JP4919145B2 (en) * 2006-04-25 2012-04-18 ケイ・アイ化成株式会社 Industrial bactericidal preservatives
US8309231B2 (en) * 2006-05-31 2012-11-13 Usg Interiors, Llc Acoustical tile
US7906463B2 (en) * 2006-08-02 2011-03-15 Kemira Chemicals Inc. Biocide for well stimulation and treatment fluids
US7786054B2 (en) * 2006-08-02 2010-08-31 Kemira Chemicals, Inc. Biocide for well stimulation and treatment fluids
EP2139448A1 (en) * 2007-03-21 2010-01-06 Dow Global Technologies Inc. Hair care composition
US9139796B2 (en) * 2007-07-24 2015-09-22 Dow Global Technologies Llc Methods of and formulations for reducing and inhibiting the growth of the concentration of microbes in water-based fluids and systems used with them
US8952199B2 (en) 2007-07-24 2015-02-10 Dow Global Technologies Llc Methods of and formulations for reducing and inhibiting the growth of the concentration of microbes in water-based fluids and systems used with them
CN103704208B (en) * 2009-05-26 2015-11-25 陶氏环球技术有限责任公司 Glutaraldehyde base biocidal composition and using method
US10174239B2 (en) * 2010-02-09 2019-01-08 Baker Hughes, A Ge Company, Llc Process for preventing or mitigating biofouling
US8536259B2 (en) 2010-06-24 2013-09-17 Usg Interiors, Llc Formaldehyde free coatings for panels
WO2017100160A1 (en) * 2015-12-07 2017-06-15 Solvay Usa Inc. Well-treatment fluids composition
US20210052524A1 (en) * 2017-11-06 2021-02-25 Dermalena Di Calderan Andrea N-acetylcysteine and urea-based formulation for the treatment of dermatological disorders
CN109647136B (en) * 2019-03-04 2021-07-13 湖南恪源环境科技有限公司 Cypress extract and its preparation method and formaldehyde adsorbent
AU2021308680A1 (en) 2020-07-17 2023-02-16 Sterilex, Llc Disinfectant/sanitizer solutions
KR20220013747A (en) * 2020-07-27 2022-02-04 이동칠 Furniture surface material with enhanced antibacterial, eco-friendliness and abrasion resistance, and its manufacturing method

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4585656A (en) * 1984-08-20 1986-04-29 Rosenthal Harold R Treatment of herpes
US4844891A (en) * 1988-02-03 1989-07-04 Lonza, Inc. Admixtures of iodopropargyl compounds and a formaldehyde donor
US5424324A (en) * 1989-11-17 1995-06-13 Rohm And Haas Company Use of carbonyl stabilizers for 3-isothiazolones
ZA933464B (en) * 1992-05-21 1993-12-20 Lonza Ag A method for preparing low free formaldehyde methylolhydantoins and compositions thereof
US5252744A (en) * 1992-05-21 1993-10-12 Lonza Inc. Process for preparing methylolhydantoins
BR9701048A (en) * 1994-08-12 1998-12-15 Procter & Gamble Non-complex odor cyclodextrin solutions on inanimate surfaces
US5804203A (en) * 1994-12-21 1998-09-08 Cosmederm Technologies Topical product formulations containing strontium for reducing skin irritation
US6143204A (en) * 1998-06-19 2000-11-07 Lonza Inc. Stabilization of iodopropynl compounds
US6656456B2 (en) * 1998-11-23 2003-12-02 The Procter & Gamble Company Skin deodorizing compositions
ATE415969T1 (en) * 1999-05-07 2008-12-15 Wockhardt Ltd (S)-BENZOQUINOLICIN CARBOXYLIC ACIDS AND THEIR USE AS ANTIBACTERIAL AGENTS
US6121302A (en) * 1999-05-11 2000-09-19 Lonza, Inc. Stabilization of isothiazolone
BR0107789B1 (en) * 2000-01-31 2011-09-06 method for reducing slime in a circulating water slurry.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2004017736A1 *

Also Published As

Publication number Publication date
AU2003259934A1 (en) 2004-03-11
AU2003259934B2 (en) 2009-05-14
CN100456932C (en) 2009-02-04
DE60311486D1 (en) 2007-03-15
NZ538638A (en) 2007-02-23
KR20050058426A (en) 2005-06-16
ZA200501309B (en) 2006-03-29
JP2005536552A (en) 2005-12-02
CR7730A (en) 2005-09-06
DE60311486T2 (en) 2007-11-08
ATE352204T1 (en) 2007-02-15
MXPA05001977A (en) 2005-09-30
CA2495893A1 (en) 2004-03-04
BR0313610A (en) 2005-06-21
EP1545210B1 (en) 2007-01-24
ES2279217T3 (en) 2007-08-16
WO2004017736A1 (en) 2004-03-04
CN1684585A (en) 2005-10-19
ECSP055667A (en) 2005-08-11
US20040102501A1 (en) 2004-05-27

Similar Documents

Publication Publication Date Title
EP1545210B1 (en) Stable, low free formaldehyde, synergistic antimicrobial compositions of aldehyde donors and dehydroacetic acid
US5707993A (en) Glycine anhydride dimethylol as a biocide and preservative
US5670160A (en) Preservatives and their use
US4906274A (en) Organic stabilizers
KR0137027B1 (en) Biocides
HU203647B (en) Synergistic bactericidal and/or fungicidal compositions comprising isothiazolone derivatives
US6143204A (en) Stabilization of iodopropynl compounds
EP0741517B1 (en) Synergistic antimicrobial compositions containing a halogenated acetophenone and an organic acid
KR20160058875A (en) Microbicidal composition comprising a benzoate or sorbate salt
US6114366A (en) Broad spectrum preservative
US6255331B1 (en) Stable biocidal compositions
US6121302A (en) Stabilization of isothiazolone
JP4171540B2 (en) Microbicidal composition and method for inhibiting microbial growth
HK1084299A (en) Stable, low free formaldehyde, synergistic antimicrobial compositions of aldehyde donors and dehydroacetic acid
MXPA00001754A (en) Stabilized mixtures of an iodopropargyl compound and a formaldehyde donor

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050321

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

RAX Requested extension states of the european patent have changed

Extension state: LT

Payment date: 20050321

Extension state: LV

Payment date: 20050321

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: LONZA, INC.

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: LT LV

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070124

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070124

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070124

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070124

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 60311486

Country of ref document: DE

Date of ref document: 20070315

Kind code of ref document: P

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070424

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20070425

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070625

LTIE Lt: invalidation of european patent or patent extension

Effective date: 20070124

ET Fr: translation filed
NLV1 Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2279217

Country of ref document: ES

Kind code of ref document: T3

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070124

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20071025

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070124

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070124

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070831

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070425

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070820

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070124

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070124

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070820

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20090612

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070124

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070725

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20090616

Year of fee payment: 7

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20090807

Year of fee payment: 7

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 20090616

Year of fee payment: 7

Ref country code: CH

Payment date: 20090701

Year of fee payment: 7

Ref country code: DE

Payment date: 20090616

Year of fee payment: 7

Ref country code: GB

Payment date: 20090611

Year of fee payment: 7

BERE Be: lapsed

Owner name: LONZA, INC.

Effective date: 20100831

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090820

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20100820

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20100831

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20100831

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20110502

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20100820

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 60311486

Country of ref document: DE

Effective date: 20110301

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20100831

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20100831

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20110301

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20090818

Year of fee payment: 7

PGRI Patent reinstated in contracting state [announced from national office to epo]

Ref country code: IT

Effective date: 20110616

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20100820

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20111019

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20100821

PGRI Patent reinstated in contracting state [announced from national office to epo]

Ref country code: IT

Effective date: 20110616